Delivery Order SPE2DB20D3103-SPE2DB24FM8X1

Award Date 3/4/24
Potential Completion Date 3/5/24
Potential Value $26K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,184.28, is for the supply of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product. The IDC has a total ceiling value of $999,999,999 and runs through November 2026, serving as a primary vehicle for DLA to procure a...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor in the United States. The contract has a ceiling value of $45,835.04 and is for the delivery of Stelara 90 mg/mL syringes. This delivery order is part of a larger $999,999,999 IDC with the DLA Troop Support Medical, which provides a comprehensive range of medical commodities to support...
This is a delivery order under a large Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $999,999,999, covers a broad range of pharmaceutical and medical supply products to support military healthcare programs globally. The specific delivery order being referenced is for the supply of 90 mg/mL Stelara syringes, a specialty medication, with a ceiling...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order under the DLA's Indefinite Delivery Contract (IDC) valued at $999,999,999, which runs through November 2026. The contract provides a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials,...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $103,995.55, is for the delivery of Stelara 90 mg/mL syringes. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as the primary vehicle for...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen Drug Corp (the prime contractor) and the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at up to $999,999,999 through December 2025, allows DLA to efficiently procure a comprehensive range of pharmaceutical and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical equipment, to support military treatment programs and...
This federal contract award to Amerisourcebergen Drug Corp (a major pharmaceutical distributor) is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical valued at $999,999,999. The contract covers a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas to support military...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Stelara 90 mg/mL syringes. The $19,773.27 firm fixed-price contract has an ultimate completion date of August 23, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order is for $648,445.10 and covers a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple...
The U.S. Defense Logistics Agency (DLA) has awarded a delivery order worth $14,751.21 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide STELARA 90 MG/ML syringes. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FM8X1
    Delivery Order

This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The delivery order, valued at $25,911.21, is for the supply of Stelara 90 mg/mL syringes. The IDC held by AmerisourceBergen with the DLA is valued at $999,999,999 and runs through November 2026, providing a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs. These contracts enable the efficient procurement of essential pharmaceutical and medical supplies for the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 11:52 AM